InflaRx Share Price
NASDAQ: IFRX | HealthcareInflaRx Stock Performance
InflaRx Share Price Today
As of 19 November 2026, InflaRx N.V.'s share price is $1.10. The stock opened at $1.15, compared to its previous close of $1.15. During today's trading session, InflaRx N.V.'s share price traded between $1.06 and $1.19, with an average price of $1.13. Over the past 52 weeks, the stock has recorded a high of $2.94 and a low of $0.80. In terms of performance, InflaRx N.V.'s share price has declined by 54.17% over the last six months and is down 13.04% on a year-on-year basis.
InflaRx Share Price Chart
InflaRx Annual Profit & Loss
All figures in USD
InflaRx Balance Sheet
All figures in USD Million
InflaRx Cash Flow
All figures in USD Million
About InflaRx
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
InflaRx Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.71 | $1.10 | -34.13% |
Oct 2026 | $1.81 | $1.67 | -7.73% |
Sep 2026 | $2.13 | $1.81 | -20.09% |
Aug 2026 | $1.68 | $2.27 | +34.02% |
Jul 2026 | $2.21 | $1.69 | -24.72% |
Jun 2026 | $2.40 | $2.25 | -6.46% |
May 2026 | $2.03 | $2.40 | +15.66% |
Apr 2026 | $0.90 | $2.08 | +141.56% |
Mar 2026 | $0.91 | $0.86 | -6.43% |
Feb 2026 | $0.91 | $0.92 | +4.20% |
Jan 2026 | $1.05 | $0.88 | -13.63% |
Dec 2025 | $1.23 | $1.02 | -19.37% |